PROCESS FOR PREPARING[R-[R*,S*-(Z)]]-7-[(2-AMINO-2-CARBOXYETHYL)THIO]-2-[((2,2-DIMETHYLCYCLOPROPYL) CARBONYL]AMINO-2-HEPTENOIC ACID SALT Abstract of the Invention Disclosed herein is a process for preparing [R-[R*,S*-(Z)]]-7-[(2-amino-2-carboxyethyl)thio]-2-[((2,2-dimethylcyclopropyl) carbonyl]amino-2-heptenoic ...

This invention relates to an improved process of preparing Pen-GESO by means of catalytic oxidation of Pen-GES.

PROCESS FOR ISOLATING PURE CRYSTALLINE IMIPENEM Abstract of the Invention The present invention discloses the cost effective and industrially viable process for the isolation of highly pure crystalline imipenem, which comprises adjusting the pH of basified water followed by addition of crude imipenem to it at ...

NOVEL POLYMORPHS OF 2-[3-CYANO-4-(2-METHYLPROPOXY)PHENYL]-4-METHYL-5-THIAZOLE CARBOXYLIC ACID AND PROCESSES FOR PREPARING THE SAME The present invention discloses novel polymorphs of febuxostat. The novel crystalline polymorphs of febuxostat, hereinafter referred as crystal III and cystal IV are disclosed. Also ...

The present invention relates to a rapid solvation process involved in the production of a solvate. The present invention provides a process for producing p-nitro benzyl thienamycin solvate, by short path isothermal solvation (SPIS). The short path isothermal solvation is achieved by preparing a hot non-interfering ...

Disclosed herein is a process for preparing highly pure 7-amino-3-vinyl cephalosporanic acid (7-AVCA) with less than 0.1% of 7-amino desacetoxy cephalosporanic acid (7-ADCA) impurity via salt of 7-(2-phenyl acetamido) vinyl cephalosporanic acid (7-PVCA).

The present invention is provided an improved process for the isolation of Minocycline free base, wherein all impurities are controlled, especially impurity 4-epimer minocycline to very low levels.

The present invention relates to a process for the preparation of highly pure N-[2-butyl-3- [4-[3-(dibutylamino)propoxy]benzoyl]-5-benzofuranyl]methanesulfonamide and pharmaceutically acceptable salts thereof having HPLC purity greater than 99.5%..

Disclosed   herein   a   process   for   producing   pure   (S)-N-[[3-[3-fluoro-4-(4- morpholinyl)phenyl]-2-oxo-5-oxazoIidinyl]methyl]acetamide(Linezolid) and its polymorphic Form

Disclosed herein is a process for preparing imipenem monohydrate in crystalline form having color value of less than about 0.15 Absorbance Unit.

Disclosed herein is a process for preparing highly pure Citicoline (CDP-Choline) or sodium salt of Citicoline with the aid of dicarboxylic acid or its salts. The process of the present invention results in Citicoline with a purity of more than 99% measured by HPLC.

The present invention relates to one pot process for preparing enantiopure N-protected L-tert-leucine or its salts by means of reductive amination.

The present invention relates to an improved process for the preparation of substantially pure Paliperidone.

PROCESS FOR PREPARING AMORPHOUS CEFDITOREN PIVOXIL Abstract of the Invention Disclosed herein is a process for preparing highly pure amorphous cefditoren pivoxil from crude cefditoren pivoxil.